Bp. Roques et al., STRUCTURE-BASED DESIGN AND PHARMACOLOGICAL PROPERTIES OF POTENT SELECTIVE AND SYSTEMICALLY ACTIVE CCK-B PEPTIDOMIMETICS, Bioorganic & medicinal chemistry letters, 3(5), 1993, pp. 847-850
Selective CCK-A and CCK-B agonists and antagonists, having all the cri
teria required to be administered systemically have been developed. pB
C 264, a selective CCK-B agonist has permitted the in vitro and in viv
o characterization of brain receptors, and has been used to establish
the involvement of CCK-B receptors in anxiety-related behaviour.